1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Natco Pharma Limited

Natco Pharma Limited

NATCOPHARM.NS
Natco Pharma LimitedIN flagNational Stock Exchange of India
932.00
INR
+0.60
- -
166.93BMarket Cap

Total Valuation

Natco Pharma Limited carries a market capitalization of 166.93B, placing it among publicly traded companies globally. Its enterprise value stands at 152.91B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap166.93B
Enterprise Value152.91B

Share Statistics

Natco Pharma Limited currently has 179.11M shares outstanding.

Shares Outstanding179.11M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Natco Pharma Limited trades at a trailing price-to-earnings ratio of 12.30. The price-to-sales ratio is 4.28, and the price-to-book ratio stands at 487.36.

PE Ratio12.30
PS Ratio4.28
PB Ratio487.36
P/TBV Ratio1.95
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Natco Pharma Limited trades at an EV/EBITDA multiple of 12.43 and an EV/FCF ratio of 452.74. The EV/Sales ratio of 3.75 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 12.43 provides insight into valuation relative to core operating earnings.

EV / Sales3.75
EV / EBITDA12.43
EV / EBIT12.43
EV / FCF452.74

Financial Position

Natco Pharma Limited maintains a current ratio of 3.01, meaning it holds 3.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 7.74, indicating elevated leverage, while an interest coverage ratio of 33.51 demonstrates strong ability to service its debt obligations.

Current Ratio3.01
Quick Ratio1.71
Debt / Equity7.74
Debt / EBITDA0.58
Interest Coverage33.51

Financial Efficiency

Natco Pharma Limited posts a return on equity of 44.90 and a return on invested capital of 12.66.

Return on Equity (ROE)44.90
Return on Assets (ROA)14.40
Return on Invested Capital (ROIC)12.66
Return on Capital Employed (ROCE)39.70
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover0.82

Taxes

Over the trailing twelve months, Natco Pharma Limited has paid 1.19B in income taxes, reflecting an effective tax rate of 7.98.

Income Tax1.19B
Effective Tax Rate7.98

Stock Price Statistics

Natco Pharma Limited's stock has declined approximately -4.2728% over the past 52 weeks. The 50-day moving average sits at 1,020.97, while the 200-day moving average is 933.45.

Beta (5Y)N/A
52-Week Price Change-4.2728%
50-Day Moving Average1,020.97
200-Day Moving Average933.45
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Natco Pharma Limited generated 40.78B in revenue and converted that into 14.19B in net income, yielding earnings per share of 79.20. EBITDA reached 12.30B, while operating income came in at 12.30B.

Revenue40.78B
Gross Profit33.88B
Operating Income12.30B
Pretax Income14.91B
Net Income14.19B
EBITDA12.30B
EBIT12.30B
Earnings Per Share (EPS)79.20

Balance Sheet

Natco Pharma Limited holds 28.71B in cash and equivalents against 7.14B in total debt, resulting in a net debt position of 5.08B. Total book value stands at 358.00M, with working capital of 33.71B providing operational flexibility.

Cash & Cash Equivalents28.71B
Total Debt7.14B
Net Debt5.08B
Equity (Book Value)358.00M
Book Value Per Share2.00
Working Capital33.71B

Margins

Natco Pharma Limited operates with a gross margin of 83.07, reflecting its pricing power and cost economics. The operating margin of 30.16 and net profit margin of 34.78 provide insight into operational efficiency.

Gross Margin83.07
Operating Margin30.16
Pretax Margin36.55
Profit Margin34.78
EBITDA Margin30.16

Stock Splits

Natco Pharma Limited's most recent stock split took place on November 26, 2015 with a 1:5 split ratio.

Last Split Date11/26/2015
Split Ratio1:5

Scores

Natco Pharma Limited posts an Altman Z-Score of 6.78, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score6.78